What vancomycin dosing regimen should be used for a 75‑kg patient with staphylococcal bacteremia and an estimated creatinine clearance of 37 mL/min?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Vancomycin Dosing for Staphylococcal Bacteremia with CrCl 37 mL/min

For a 75 kg patient with staphylococcal bacteremia and creatinine clearance of 37 mL/min, give an initial loading dose of 15-20 mg/kg (1125-1500 mg, round to 1000-1500 mg) infused over 1.5-2 hours, followed by a maintenance dose of approximately 555 mg/24 hours (calculated as 15 × 37 = 555 mg/day per FDA dosing table), which can be practically administered as 500-750 mg every 24 hours. 1

Rationale and Dosing Algorithm

Loading Dose (Critical First Step)

  • Give at least 15 mg/kg even with renal impairment to achieve rapid therapeutic concentrations 1
  • For this 75 kg patient: 15 mg/kg = 1125 mg (can round to 1000-1500 mg)
  • Infuse over 1.5-2 hours to minimize infusion-related reactions 1
  • This loading dose is non-negotiable regardless of renal function to achieve prompt therapeutic serum concentrations

Maintenance Dosing Based on Renal Function

The FDA label provides a specific dosing table: vancomycin dose (mg/24h) = 15 × CrCl (mL/min) 1

For CrCl 37 mL/min:

  • 15 × 37 = 555 mg/24 hours
  • Practical dosing: 500-750 mg every 24 hours OR 250-375 mg every 12 hours

The FDA table shows for CrCl 40 mL/min = 620 mg/24h and CrCl 30 mL/min = 465 mg/24h, so 555 mg/24h fits appropriately 1

Target Trough Levels for Bacteremia

For serious infections like bacteremia, target trough concentrations of 15-20 mg/L are recommended to achieve AUC/MIC ≥400 2. This is higher than the standard 10-15 mg/L target for less severe infections.

Critical Monitoring Requirements

Measure trough level before the 4th dose (steady state) 2:

  • If trough <15 mg/L: increase maintenance dose
  • If trough >20 mg/L: decrease maintenance dose or extend interval
  • For this patient with impaired renal function, monitoring is essential as they are at higher risk for both subtherapeutic levels (due to potentially augmented clearance in critical illness) and toxicity 2

Important Caveats

Augmented Renal Clearance Risk

Even with CrCl 37 mL/min, critically ill patients may have augmented drug clearance that is not reflected in creatinine-based estimates 3, 4. If troughs remain low despite appropriate dosing:

  • Consider higher maintenance doses (up to 1000 mg/24h may be needed)
  • Measure levels more frequently
  • Consider continuous infusion if intermittent dosing fails to achieve targets

Nephrotoxicity Monitoring

With target troughs of 15-20 mg/L, nephrotoxicity risk increases 2. Monitor:

  • Serum creatinine every 2-3 days
  • Define nephrotoxicity as: ≥0.5 mg/dL increase OR ≥50% increase from baseline on ≥2 consecutive measurements 2
  • Avoid concurrent nephrotoxins (aminoglycosides, piperacillin-tazobactam) when possible 5

Dosing Adjustments

The initial FDA table-based dosing is a starting point only. Individual pharmacokinetic variability is substantial, especially with:

  • Fluctuating renal function (common in bacteremia/sepsis)
  • Fluid resuscitation altering volume of distribution
  • Vasopressor use affecting clearance 6, 7

Do not rely on nomograms alone—therapeutic drug monitoring is mandatory for bacteremia 2.

Alternative Consideration

If MIC is ≥2 mg/L, achieving AUC/MIC ≥400 may be impossible with conventional vancomycin dosing even with normal renal function 2. In this scenario, strongly consider alternative agents (daptomycin, linezolid, ceftaroline) rather than pushing vancomycin doses higher and risking toxicity.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.